Syn - Finechem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 23-12-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.40 M
as on 23-12-2024
- Satisfied Charges ₹ 1.35 Cr
as on 23-12-2024
About Syn - Finechem Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.40 M. The company has closed loans amounting to ₹1.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashwik Battu, Chandra Battu, Battu Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TG2003PTC041429
- Company No.
041429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Syn - Finechem Laboratories Private Limited offer?
Syn - Finechem Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Industrial Chemicals & Supplies, Chemical Intermediates, Aroma Chemicals, Organic and Inorganic Solvents, Ketones, Pyridine Derivatives.
Who are the key members and board of directors at Syn - Finechem Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saida Battu  | Managing Director | 22-Aug-2003 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashwik Battu | Director | 27-May-2011 | Current |
| Chandra Battu | Director | 22-Aug-2003 | Current |
| Battu Reddy | Director | 27-May-2011 | Current |
Financial Performance of Syn - Finechem Laboratories.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Syn - Finechem Laboratories?
Unlock access to Syn - Finechem Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Synfine Drugs Private LimitedActive 7 years 9 monthsChandra Battu and Saida Battu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Oct 2023 | ₹2.46 M | Open |
Hdfc Bank Limited Creation Date: 12 Sep 2023 | ₹2.64 M | Open |
Hdfc Bank Limited Creation Date: 08 Dec 2021 | ₹0.30 M | Open |
How Many Employees Work at Syn - Finechem Laboratories?
Unlock and access historical data on people associated with Syn - Finechem Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syn - Finechem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syn - Finechem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
